Patterson-UTI (PTEN) reported $1.22 billion in revenue for the quarter ended June 2025, representing a year-over-year decline of 9.6%. EPS of -$0.06 for the same period compares to $0.05 a year ago.
The reported revenue compares to the Zacks Consensus Estimate of $1.21 billion, representing a surprise of +1.02%. The company delivered an EPS surprise of -50%, with the consensus EPS estimate being -$0.04.
While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.
Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.
Here is how Patterson-UTI performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:View all Key Company Metrics for Patterson-UTI here>>>
Shares of Patterson-UTI have returned +4.1% over the past month versus the Zacks S&P 500 composite's +3.4% change. The stock currently has a Zacks Rank #4 (Sell), indicating that it could underperform the broader market in the near term.Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
This article originally published on Zacks Investment Research (zacks.com).
| Aug-14 | |
| Aug-12 | |
| Jul-30 | |
| Jul-30 | |
| Jul-29 | |
| Jul-29 | |
| Jul-14 | |
| Jul-09 | |
| Jul-06 | |
| Jun-05 | |
| May-07 | |
| May-06 | |
| Apr-24 | |
| Apr-23 | |
| Apr-22 |
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, alerts, and much more.
Learn more about Finviz Elite